About
Paul is a co–founder and currently serves as the Chief Scientific Officer of Kapa Biosystems, a company using protein evolution technology for the development of life science tools and kits. Previously he co–founded both Agencourt Bioscience Corporation and Agencourt Personal Genomics. Agencourt Bioscience was a market leader in the genomic services and DNA purification markets which was successfully sold to Beckman Coulter in 2005. Agencourt Personal Genomics was acquired by Applied Biosystems and its technology was used as the basis for the SOLiDTM next–generation DNA sequencer. Previous to these positions, Paul was a member of technology development group at the Whitehead/MIT Center for Genome Research where he developed automation and biochemical processes for the scale–up effort to sequence the Human Genome. Paul holds a BS in Biology and Anthropology from Emory University.
Position in the VCSift Database
- • 2 investors at Table Mountain Ventures are tracked.
- • 658 investors hold the Principal role in VCSift. Paul McEwan is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Paul
Search Investors